Syrowatka Ania, Motulsky Aude, Kurteva Siyana, Hanley James A, Dixon William G, Meguerditchian Ari N, Tamblyn Robyn
Clinical and Health Informatics Research Group, McGill University, Montreal, QC, Canada.
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Breast Cancer Res Treat. 2017 Sep;165(2):229-245. doi: 10.1007/s10549-017-4290-9. Epub 2017 May 28.
Unmanaged distress has been shown to adversely affect survival and quality of life in breast cancer survivors. Fortunately, distress can be managed and even prevented with appropriate evidence-based interventions. Therefore, the objective of this systematic review was to synthesize the published literature around predictors of distress in female breast cancer survivors to help guide targeted intervention to prevent distress.
Relevant studies were located by searching MEDLINE, Embase, PsycINFO, and CINAHL databases. Significance and directionality of associations for commonly assessed candidate predictors (n ≥ 5) and predictors shown to be significant (p ≤ 0.05) by at least two studies were summarized descriptively. Predictors were evaluated based on the proportion of studies that showed a significant and positive association with the presence of distress.
Forty-two studies met the target criteria and were included in the review. Breast cancer and treatment-related predictors were more advanced cancer at diagnosis, treatment with chemotherapy, longer primary treatment duration, more recent transition into survivorship, and breast cancer recurrence. Manageable treatment-related symptoms associated with distress included menopausal/vasomotor symptoms, pain, fatigue, and sleep disturbance. Sociodemographic characteristics that increased the risk of distress were younger age, non-Caucasian ethnicity, being unmarried, and lower socioeconomic status. Comorbidities, history of mental health problems, and perceived functioning limitations were also associated. Modifiable predictors of distress were lower physical activity, lower social support, and cigarette smoking.
This review established a set of evidence-based predictors that can be used to help identify women at higher risk of experiencing distress following completion of primary breast cancer treatment.
已表明未得到管理的痛苦会对乳腺癌幸存者的生存和生活质量产生不利影响。幸运的是,通过适当的循证干预措施,痛苦是可以得到管理甚至预防的。因此,本系统评价的目的是综合已发表的关于女性乳腺癌幸存者痛苦预测因素的文献,以帮助指导针对性干预措施来预防痛苦。
通过检索MEDLINE、Embase、PsycINFO和CINAHL数据库来查找相关研究。对常见评估的候选预测因素(n≥5)以及至少两项研究显示具有显著性(p≤0.05)的预测因素的关联显著性和方向性进行描述性总结。根据显示与痛苦存在显著正相关的研究比例对预测因素进行评估。
42项研究符合纳入标准并被纳入本评价。乳腺癌及与治疗相关的预测因素包括诊断时癌症分期较晚、接受化疗、初次治疗时间较长、刚进入 survivorship阶段以及乳腺癌复发。与痛苦相关的可管理的治疗相关症状包括更年期/血管舒缩症状、疼痛、疲劳和睡眠障碍。增加痛苦风险的社会人口学特征包括年龄较小、非白种人种族、未婚以及社会经济地位较低。合并症、心理健康问题史以及感知到的功能受限也与之相关。痛苦的可改变预测因素包括身体活动较少、社会支持较低以及吸烟。
本评价确定了一组循证预测因素,可用于帮助识别在完成原发性乳腺癌治疗后经历痛苦风险较高的女性。